Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Small Cell Lung Carcinoma
×
pegfilgrastim
×
Clear all
Filters
3
NCT01840579
2021-06-22
MK-3475-011
Merck Sharp & Dohme LLC
Phase 1
Completed
57 enrolled
60 charts